Comment on FDA authorizes Novavax Covid-19 vaccine for emergency use in ages 12-17

The US Food and Drug Administration authorized Novavax's Covid-19 vaccine on Friday for emergency use in adolescents. It is the fourth coronavirus vaccine available in the United States and, unlike the others, is uses a protein-based technology.